Overview

Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare and evaluate the single-dose oral bioavailability and to monitor the safety of subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Atorvastatin
Atorvastatin Calcium
Calcium
Calcium, Dietary